What is Lucid Diagnostics 3-Year Share Buyback Ratio?
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Lucid Diagnostics's current 3-Year Share Buyback Ratio was -21.80%.
The historical rank and industry rank for Lucid Diagnostics's 3-Year Share Buyback Ratio or its related term are showing as below:
LUCD'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -21.8 Med: -4.6 Max: -3.1
Current: -21.8
During the past 6 years, Lucid Diagnostics's highest 3-Year Share Buyback Ratio was -3.10%. The lowest was -21.80%. And the median was -4.60%.
LUCD's 3-Year Share Buyback Ratio is ranked worse than 78.99% of 671
companies
in the Medical Devices & Instruments industry
Industry Median: -4.4
vs LUCD: -21.80
Competitive Comparison of Lucid Diagnostics's 3-Year Share Buyback Ratio
For the Medical Devices subindustry, Lucid Diagnostics's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lucid Diagnostics's 3-Year Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lucid Diagnostics's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Lucid Diagnostics's 3-Year Share Buyback Ratio falls into.
Lucid Diagnostics 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
Lucid Diagnostics (NAS:LUCD) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Lucid Diagnostics 3-Year Share Buyback Ratio Related Terms
Thank you for viewing the detailed overview of Lucid Diagnostics's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LUCD has been successfully added to your